Circulating extracellular vesicle lipidomics identifies distinct signatures of amyotrophic lateral sclerosis and spinal muscular atrophy
Ricotti, V.; Fogel, A.; Vandenbosch, M.; Cerri, F.; Ala, P.; Capstick, A.; Rossi, R.; Gerardi, F.; Jacobs, R.; Mercuri, E.; Sansone, V.; Shaw, P. J.; Barnaghi, P.; Voit, T.
Show abstract
Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative disorder lacking established biomarkers of underlying disease biology. Here, we identify lipidomic signatures of circulating extracellular vesicles (EVs) that distinguish ALS from neurologically healthy controls and related neuromuscular diseases. Using mass spectrometry-based profiling and multivariate modelling, we separate ALS (n=77) from healthy controls (n=89) with an area under the receiver operating characteristic curve (AUROC) of 0.90 (95% CI 0.85-0.94), rising to 0.92 (0.89-0.96) when low-confidence predictions are withheld, and retaining performance in an independent cohort (n=119; AUROC 0.78, 0.70-0.86). In Tofersen-treated SOD1-ALS patients, biomarker trajectories change in parallel with clinical measures while individuals with spinal muscular atrophy (n=50) exhibit a lipid fingerprint distinct from that observed in ALS, supporting disease specificity within a shared systemic framework of abnormal systemic lipogenesis. These findings establish EV-associated lipid signatures as a systemic, blood-based biomarker platform for ALS diagnosis, stratification, and treatment monitoring, with structurally distinct lipid species indicating widespread membrane remodelling.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Single-cell transcriptomic landscape of the neuroimmune compartment in amyotrophic lateral sclerosis brain and spinal cord 93%
- Nuclear depletion of RNA binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis 92%
- Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease 92%
Similar papers in this journal
- Skeletal muscle biomarkers of amyotrophic lateral sclerosis: a large-scale, multi-cohort proteomic study 94%
- Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis relates to lower motor neuron dysfunction 90%
- Plasma MIA, CRP, and albumin predict cognitive decline in Parkinson’s Disease 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.